Skip to content

CapEx at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$347M+33.5%
Inhibrx Biosciences, Inc. logo
Inhibrx Biosciences, Inc.INBX
$0-100%
Corvus Pharmaceuticals logo
Corvus PharmaceuticalsCRVS
$91K+153%
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
$1.78M+58.4%
Janux Therapeutics logo
Janux TherapeuticsJANX
$273K-26.4%
Vera Therapeutics logo
Vera TherapeuticsVERA
$23K-87.7%

Other financials

Income statement

See full
Revenue-
Net income-$7.5M-13.1%
EPS (diluted)-$0.13+13.3%

Balance sheet

See full
Cash & equivalents$6.3M+1.3%
Total debt$456.9K+178%
Total equity$23.2M+135%
Total assets$29.7M+103%

Cash flow

See full
Operating cash flow-$4.4M+6.9%
Free cash flow-$4.5M+6.7%

Valuation

See full
Market cap$155.39M+45.8%
Enterprise value$149.54M+52.3%

Returns & leverage

See full
Return on equity-187.2%
Debt / equity0.0×
Current ratio1.2×-1.8×

Where this comes from

Reported directly by TuHURA Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

The official record: TuHURA Biosciences, Inc.’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about TuHURA Biosciences, Inc.'s capex.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is TuHURA Biosciences, Inc.'s capex?
TuHURA Biosciences, Inc. (HURA) reported capex of $48.85K in Q1 2026.
How has TuHURA Biosciences, Inc.'s capex changed year-over-year?
TuHURA Biosciences, Inc.'s capex increased by 14.5% year-over-year, from $42.67K to $48.85K.
What does capex mean?
Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.